SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 269.80 |
| Enterprise Value ($M) | 263.78 |
| Book Value ($M) | 4.95 |
| Book Value / Share | 0.81 |
| Price / Book | 54.54 |
| NCAV ($M) | 4.95 |
| NCAV / Share | 0.81 |
| Price / NCAV | 54.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.31 |
| Return on Assets (ROA) | -0.88 |
| Return on Equity (ROE) | -1.16 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.41 |
| Current Ratio | 5.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.07 |
| Assets | 6.07 |
| Liabilities | 1.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | |||
| 13D/A | Tactic Pharma LLC | 19.20 | ||
| 13G | Ra Capital Management, L.p. | 9.70 | ||
| 13G | Astrazeneca Plc | 9.90 | ||
| 13G | Tang Capital Management Llc | 5.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 14,374 | 79,421 | 18.10 | |
| 16,364 | 79,226 | 20.65 | |
| 18,305 | 94,185 | 19.44 | |
| 10,764 | 69,934 | 15.39 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MEIP – MEI Pharma, Inc. | MIRA – MIRA Pharmaceuticals, Inc. |
| MLTX – MoonLake Immunotherapeutics | MRKR – Marker Therapeutics, Inc. |
| MTEX – Mannatech, Incorporated |
Financial data and stock pages provided by
Fintel.io